1 |
Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev. Cell. 19, 491-505.
DOI
ScienceOn
|
2 |
Pan, D. (2007) Hippo signaling in organ size control. Genes Dev. 21, 886-897.
DOI
ScienceOn
|
3 |
Enderle, L. and McNeill, H. (2013) Hippo gains weight: added insights and complexity to pathway control. Sci. Signal. 6, re7.
DOI
ScienceOn
|
4 |
Harvey, K. F., Zhang, X. and Thomas, D. M. (2013) The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257.
DOI
ScienceOn
|
5 |
Yu, F. X. and Guan, K. L. (2013) The Hippo pathway: regulators and regulations. Genes Dev. 27, 355-371.
DOI
ScienceOn
|
6 |
Ma, Y., Yang, Y., Wang, F., Wei, Q. and Qin, H. (2014) Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Int. J. Cancer [Epub ahead of print]
|
7 |
Clevers, H. and Nusse, R. (2012) Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205.
DOI
ScienceOn
|
8 |
Kim, W., Kim, M. and Jho, E. H. (2013) Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem. J. 450, 9-21.
DOI
ScienceOn
|
9 |
Massague, J. (2012) TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630.
DOI
ScienceOn
|
10 |
Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., Wrana, J. L. and Attisano, L. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev. Cell 18, 579-591.
DOI
ScienceOn
|
11 |
Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M. and Piccolo, S. (2012) Role of TAZ as mediator of Wnt signaling. Cell 151, 1443-1456.
DOI
ScienceOn
|
12 |
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., Fassina, A., Cordenonsi, M. and Piccolo, S. (2014) YAP/TAZ Incorporation in the beta-Catenin Destruction Complex Orchestrates the Wnt Response. Cell 158, 157-170.
DOI
ScienceOn
|
13 |
Beyer, T. A., Weiss, A., Khomchuk, Y., Huang, K., Ogunjimi, A. A., Varelas, X. and Wrana, J. L. (2013) Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5, 1611-1624.
DOI
ScienceOn
|
14 |
Fernandez, L. A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D. and Kenney, A. M. (2009) YAP1 is amplified and up-regulated in hedgehog- associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 23, 2729-2741.
DOI
ScienceOn
|
15 |
Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H. and Sekido, Y. (2012) TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J. Exp. Med. 209, 479-494.
DOI
|
16 |
Attisano, L. and Wrana, J. L. (2013) Signal integration in TGF-beta, WNT, and Hippo pathways. F1000Prime Rep. 5, 17.
|
17 |
Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X. D., Mills, G. B. and Guan, K. L. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791.
DOI
ScienceOn
|
18 |
Regimbald-Dumas, Y. and He, X. (2011) Wnt signalling: What The X@# is WTX? EMBO J. 30, 1415-1417.
DOI
ScienceOn
|
19 |
MacDonald, B. T., Tamai, K. and He, X. (2009) Wnt/beta- catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26.
DOI
ScienceOn
|
20 |
Gomez-Orte, E., Saenz-Narciso, B., Moreno, S. and Cabello, J. (2013) Multiple functions of the noncanonical Wnt pathway. Trends. Genet. 29, 545-553.
DOI
ScienceOn
|
21 |
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., 3rd and Nusse, R. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452.
DOI
ScienceOn
|
22 |
Sugimura, R. and Li, L. (2010) Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res. C. Embryo Today. 90, 243-256.
DOI
ScienceOn
|
23 |
Wang, Y. (2009) Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol. Cancer Ther. 8, 2103-2109.
|
24 |
Willert, K. and Nusse, R. (2012) Wnt proteins. Cold Spring Harb Perspect Biol. 4, a007864.
|
25 |
Kim, S. E., Huang, H., Zhao, M., Zhang, X., Zhang, A., Semonov, M. V., MacDonald, B. T., Zhang, X., Garcia Abreu, J., Peng, L. and He, X. (2013) Wnt stabilization of beta-catenin reveals principles for morphogen receptor- scaffold assemblies. Science 340, 867-870.
DOI
ScienceOn
|
26 |
Moya, I. M. and Halder, G. (2014) Discovering the Hippo pathway protein-protein interactome. Cell Res. 24, 137-138.
DOI
ScienceOn
|
27 |
Johnson, R. and Halder, G. (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug. Discov. 13, 63-79.
|
28 |
Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B. G., Rossant, J. and Wrana, J. L. (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev. Cell 19, 831-844.
DOI
ScienceOn
|
29 |
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W. M. and Pan, D. (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell 18, 288-299.
DOI
ScienceOn
|
30 |
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N. and Pan, D. (2013) Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154, 1342-1355.
DOI
ScienceOn
|
31 |
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A. and Pan, D. (2010) The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27-38.
DOI
ScienceOn
|
32 |
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C. and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761.
DOI
ScienceOn
|
33 |
Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. and Guan, K. L. (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF (beta-TRCP). Genes Dev. 24, 72-85.
DOI
ScienceOn
|
34 |
Oh, H. and Irvine, K. D. (2009) In vivo analysis of Yorkie phosphorylation sites. Oncogene 28, 1916-1927.
DOI
ScienceOn
|
35 |
Huang, J., Wu, S., Barrera, J., Matthews, K. and Pan, D. (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421-434.
DOI
ScienceOn
|
36 |
Thompson, B. J. and Cohen, S. M. (2006) The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126, 767-774.
DOI
ScienceOn
|
37 |
Nolo, R., Morrison, C. M., Tao, C., Zhang, X. and Halder, G. (2006) The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr. Biol. 16, 1895-1904.
DOI
ScienceOn
|
38 |
Neto-Silva, R. M., de Beco, S. and Johnston, L. A. (2010) Evidence for a growth-stabilizing regulatory feedback mechanism between Myc and Yorkie, the Drosophila homolog of Yap. Dev. Cell 19, 507-520.
DOI
ScienceOn
|
39 |
Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C., Schiripo, T. A., Haber, D. and Hariharan, I. K. (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478.
DOI
ScienceOn
|
40 |
Nelson, M. A., Reynolds, S. H., Rao, U. N., Goulet, A. C., Feng, Y., Beas, A., Honchak, B., Averill, J., Lowry, D. T., Senft, J. R., Jefferson, A. M., Johnson, R. C. and Sargent, L. M. (2006) Increased gene copy number of the transcription factor E2F1 in malignant melanoma. Cancer Biol. Ther. 5, 407-412.
DOI
|
41 |
Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J. and Tapon, N. (2010) Kibra is a regulator of the Salvador/ Warts/Hippo signaling network. Dev. Cell 18, 300-308.
DOI
ScienceOn
|
42 |
Genevet, A. and Tapon, N. (2011) The Hippo pathway and apico-basal cell polarity. Biochem. J. 436, 213-224.
DOI
ScienceOn
|
43 |
Makita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., Nakagawa, O., Small, E. V., Cobo-Stark, P., Igarashi, P., Murakami, M., Tominaga, J., Sato, T., Asano, T., Kurihara, Y. and Kurihara, H. (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. Renal. Physiol. 294, F542-553.
DOI
ScienceOn
|
44 |
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L. and Martin, J. F. (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461.
DOI
ScienceOn
|
45 |
Badouel, C., Gardano, L., Amin, N., Garg, A., Rosenfeld, R., Le Bihan, T. and McNeill, H. (2009) The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie. Dev. Cell 16, 411-420.
DOI
ScienceOn
|
46 |
Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A. and Nishida, E. (2012) A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. EMBO J. 31, 1109-1122.
DOI
|
47 |
Sugimura, R., He, X. C., Venkatraman, A., Arai, F., Box, A., Semerad, C., Haug, J. S., Peng, L., Zhong, X. B., Suda, T. and Li, L. (2012) Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150, 351-365.
DOI
ScienceOn
|
48 |
Li, V. S., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J., Maurice, M. M., Mahmoudi, T. and Clevers, H. (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149, 1245-1256.
DOI
ScienceOn
|